MGNet: Defining a Treatment-Responsive Biomarker for Corticosteroid Therapy in Myasthenia Gravis
14 nov 2023 ·
1 min. 42 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal PLOS One on October 10, 2023, titled "Serum metabolomics...
mostra di più
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal PLOS One on October 10, 2023, titled "Serum metabolomics of treatment response in myasthenia gravis."
Read the paper here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287654
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
mostra meno
Read the paper here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287654
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
Informazioni
| Autore | RDCRN |
| Organizzazione | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
